IO Biotech, Inc. — Director's Dealing 2022

May 13, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2022-05-11

Reporting Person: Burkavage Brian (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1500	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$8.52	2032-02-15	Common Stock (53000)		Direct

Footnotes

F1: One-fourth of these options vest on 10/29/2022, and 1/48th of these options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control.